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Lentiviral vectors have gained much attention in recent years mainly because they integrate into nondividing host-cell
genomes. For clinical applications, a safe and efficient lentiviral vector system is required. Previously, we have established
a human immunodeficiency virus type 1 (HIV-1)-derived three-plasmid lentiviral vector system for viral vector production
which includes a packaging vector pHP, a transducing vector pTV, and an envelope-encoding plasmid pHEF-VSVG. Cotrans-
fection of these three plasmids into TE671 human rhabdomyosarcoma cells routinely yields 105–106 infectious units per
milliliter in 24 h. Here we have extensively modified long terminal repeats (LTRs) of pTV to generate a safer lentiviral vector
system. The 59 U3 was replaced with a truncated cytomegalovirus (CMV) immediate early (IE) enhancer/TATA promoter and
the 39 U3 (except for the integration attachment site) was also deleted. These modifications resulted in a vector with 80%
wild-type vector efficiency. Further deletion of 39 U5 impaired vector function; however, this problem was solved by replacing
the 39 U5 with bovine growth hormone polyadenylation (bGHpA) sequence. The pTV vector containing all these modifications
including the 59 promoter substitution, the 39 U3 deletion, and the substitution of 39 U5 with bGHpA exhibited a self-
inactivating (SIN) phenotype after transduction, transduced both dividing and nondividing cells at similar efficiencies, and
produced vector titers twice as high as that of the wild-type construct. Thus, both safety and efficacy of the HP/TV vector
have been improved by these LTR modifications. Further deletion of 59 U5 impaired vector efficiency, suggesting that the 59
U5 has critical roles in vector function. © 1999 Academic Press
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Gene therapy has great potential for treating inherited
nd acquired diseases. Both viral and nonviral gene
ransfer strategies have been employed in clinical appli-
ations, although most of them are still far from perfect
Verma and Somia, 1997). Retrovirus vectors based on
oloney murine leukemia virus (MoMLV) have been very
opular, especially in ex vivo studies, because they in-
egrate into host genomes permitting long-term gene
xpression. However, retroviruses do not integrate into
ondividing cells including terminally differentiated cells
Gordon and Anderson, 1994; Marin et al., 1997; Miller et
l., 1993). This disadvantage has been overcome by
eriving vectors from lentiviruses which infect both di-
iding and nondividing cells (Poeschla et al., 1996; Verma
nd Somia, 1997).
Lentiviral vectors have been tested in tissue cultures
nd in animals and shown to effectively transduce non-
ividing cells including neurons, liver, retina, and muscle
Chang et al., 1999; Kafri et al., 1997; Miyoshi et al., 1997;
aldini et al., 1996a,b; Poeschla et al., 1998; Zufferey et
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120l., 1997). Nevertheless, safety has been a major concern
ith lentiviral vectors due to the possibility of generating
eplication-competent pathogenic virus. Unlike MLV vec-
ors, cell lines for packaging lentiviral vectors are difficult
o establish because several lentiviral gene products are
oxic to mammalian cells (Carroll et al., 1994; Kaul et al.,
998; Srinivasakumar et al., 1997). We have adopted a
NA cotransfection method for production of lentiviral
ectors (Chang et al., 1999). In this system, the lentiviral
enome is divided into two plasmids, HP and TV, for
afety reasons. Although we did not detect any replica-
ion-competent virus (RCV) from this HP/TV vector sys-
em (Chang et al., 1999), these two plasmids still contain
ative HIV sequences including the two LTRs in the
ransducing vector pTV. Therefore, the possibility of gen-
rating RCV cannot be totally ruled out. Further removal
f the HIV LTR sequences from the HP/TV vector system
ill greatly improve its safety.
Similar to all retroviruses, lentiviral LTR contains en-
ancer/promoter elements, the left integration attach-
ent site (attL) in U3, polyadenylation signal in R, and
art of the polyadenylation signal and the right integra-
ion attachment site (attR) in U5. In addition, lentiviral LTR
ontains a Tat-interacting TAR sequence overlapping the
region, which is essential for viral replication. In the
resent study, we investigated the possibility of deleting
ost of the U3 and U5 sequences in the LTRs of pTV to
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121IMPROVED LENTIVIRAL SIN VECTORSenerate an improved lentiviral self-inactivated (SIN)
ector.
RESULTS
he HP/TV lentiviral vector system
A three-plasmid lentiviral vector system has been es-
FIG. 1. HIV-1-derived lentiviral vector system. (A) HIV-1 genome struct
olypurine tract. (B) HP/TV vector system. In pHPdl20, 28 nucleotidesablished as illustrated in Fig. 1. pHPdl20 contains a (himeric promoter made of CMV-IE enhancer/TATA, an
rtificial leader sequence made of HIV TAR, and a Rous
arcoma virus (RSV) 59 splice site with a mutated RSV
ag AUG, HIV-1 gag-pol, vif, vpr, vpu, tat, rev, a mutated
nv, and an SV40 polyadenylation signal. Transducing
ector pTV contains 59 and 39 HIV-1 LTRs, part of gag,
nd part of env including RRE, an internal promoter
, integrase attachment site; SD, splice donor; c, packaging signal; ppt,
were deleted as previously described (Chang et al., 1999).ure. attCMV-IE), and a reporter gene (nlacZ). Also, an envelope-
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122 IWAKUMA, CUI, AND CHANGncoding plasmid pHEF-VSVG is used for pseudotype
irus production (Burns et al., 1993; Chang et al., 1999)
Figs. 1A and 1B). Although pHP expresses tat and rev
unctions of HIV-1, a tat expression plasmid, pCEP4tat, is
upplemented in DNA cotransfection to enhance virus
roduction. Cotransfection of the above four plasmids
nto human rhabdomyosarcoma TE671 cells routinely
roduces 105–106 infectious vectors per milliliter as de-
ermined by titration assay as illustrated in Fig. 2, which
lso shows the experimental approaches for analyses of
ifferent pTV LTR mutants.
9 U3 replacement with a heterologous
nhancer/promoter
Based on previous studies of chimeric HIV-1 LTRs
Chang et al., 1993), we replaced the U3 of the 59 LTR
FIG. 2. Experimental approach diagram. For vector production and tit
uman growth hormone plasmid pXGH5 was used as transfection co
XGH5 were cotransfected.ith a truncated CMV-IE enhancer/TATA promoter and renerated pTVDCT. This replacement eliminates the en-
ire 59 U3 of HIV-1 except for 25 nucleotides upstream of
he NFkB binding sites. When assayed for vector effi-
iency and compared with that of the wild-type construct
TVD, pTVDCT exhibited a vector titer close to wild-type
evel (Fig. 3A). To examine the chimeric promoter activity,
oly(A)1 cytoplasmic RNA was purified 42 h after co-
ransfection of the pTV DNA with a Rev expression vec-
or, pCMVrev, in the presence or absence of pCEP4tat,
ollowed by Northern blotting and hybridization using a
acZ probe. The results showed that both wt and mutant
onstructs expressed unspliced, full-length mRNA in the
bsence of Tat and both were Tat-responsive (Fig. 3B).
9 U3 deletion to generate a SIN vector
Retroviral vectors with 39 U3 mutations are SIN after
ive plasmids were cotransfected into TE671 cells as shown on the left.
o examine RNA expression of pTV vectors, pCMVrev, pCEP4tat, andration, f
ntrol. Teverse transcription (Bishop, 1983; Hwang et al., 1997;
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123IMPROVED LENTIVIRAL SIN VECTORSiyoshi et al., 1998; Olson et al., 1994; Temin, 1990;
ufferey et al., 1997). To see if the 39 U3 region in pTV can
e deleted, a series of 39 U3 deletions were made by
CR mutagenesis using primers shown in Fig. 5. We first
eleted NFkB and Sp1 binding sequences in the 39 U3
s described under Materials and Methods. This muta-
FIG. 3. Replacement of 59 U3 in pTV and study of vector function. (A
eplaced with CMV-IE enhancer/TATA promoter to generate pTVDCT-C
elative to the titer of wild-type pTVDCMVnlacZ which was arbitrarily s
TV construct is 7.3 6 0.2 3 105. (B) Northern analysis of pTVDCMVnlac
ish were cotransfected with 20 mg of pTV, 4 mg of pCMVrev, 3 mg of p
ytoplasmic poly(A)1 RNA was harvested 42 h later as described unde
n actin probe as indicated on the left. The four major vector RNA speci
enerated by using the 39 splice site in HIV env; CMV internal promote
plice site in the CMV promoter; and multiply spliced pTV RNA, gener
NA molecular weight markers are shown on the left.ion did not alter virus titer when compared with the gild-type pTV (D97 bp, pTVDCMVnlacZdl39U3kB/Sp1,
ig. 4). This encouraged us to delete more of the 39 U3
equence. Further deletions were made to include most
f the U3 sequence with or without the flanking 9098–
154 and 9512–9528 regions (according to the numeric
ystem of HIV-1 plasmid pNL4–3). These mutations were
onstructs and relative vector titers. The 59 U3 of pTVDCMVnlacZ was
cZ. Vector titer was determined as described in Fig. 2 and presented
0 with standard errors (n 5 4). The actual titer value of the wild-type
TVDCT-CMVnlacZ with or without Tat. TE671 cells in a six-well culture
t (tat1) or control pcDNAZeo/3.1(1) (tat2) DNA, and 0.1 mg of pXGH5.
rials and methods. The blot was hybridized with either a lacZ probe or
denoted on the right: genome-sized pTV RNA; singly spliced pTV RNA,
nlacZ mRNA, including a comigrating spliced RNA using a cryptic 39
using a cryptic 39 splice site in the nlacZ gene (see Cui et al., 1999).) pTV c
MVnla
et at 1.0
Z and p
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ated byenerated by PCR mutagenesis using primers c–f listed
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124 IWAKUMA, CUI, AND CHANGn Fig. 5. In all of these mutants, the left integrase attach-
ent site (attL, 24 nt) was retained which is essential for
he integration function of the pTV vector (Reicin et al.,
995). These mutants were compared with wt pTV by
otransfection with pHP in TE671 cells, and the relative
ector efficiency was determined. The results are sum-
arized in Fig. 4. The longest 39 U3 deletion did not
ppear to have any notable effects on vector titer
pTVDCMVnlacZdl39U3#1). To verify this, the 39 U3 dele-
ion #1 (D431 bp) was introduced into the chimeric con-
truct pTVDCT-CMVnlacZ to generate pTVDCT-
MVnlacZdl39U3#1. The titer assay again confirmed that
FIG. 4. Deletion of 39 U3 in pTV and study of vector function. 39 U3
ndicated and the nucleotide numbers on the map are based on pNL4
SE, upstream element. The vector titer with standard error (n 5 4) rela
n the right. The actual titer value of the wild-type pTV construct washis large U3 deletion did not have a notable effect on aector efficiency. Interestingly, we observed that the two
eletion constructs (pTVDCMVnlacZdl39U3#1 and #2),
hich lack an “upstream element” (USE), always pro-
uced lower titers than those with USE
pTVDCMVnlacZdl39U3#3 and #4), which suggests a
ositive role of USE on vector function (Fig. 4).
To see if the U3-deleted pTV vectors could be properly
everse transcribed and maintain the U3 deletion in the
rovirus, we examined the provirus formation in the
ransduced cells. TE671 cells were transduced with 39 or
oth 59 and 39 U3-deleted or wild-type U3 vectors, and
xtrachromosomal DNA was purified. Proviral intermedi-
d pTV constructs and their relative titers. The size of U3 deletion is
xample, NFkB and Sp1 binding sequences are from nt 9393 to 9489;
pTVDCMVnlacZ was determined as described in Fig. 2 and presented
.2 3 105.delete
-3; for e
tive totes in the Hirt preparation were amplified by PCR using
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125IMPROVED LENTIVIRAL SIN VECTORSnested primer set as described under Materials and
ethods. The PCR primers were designed to specifically
mplify unintegrated intermediates (circular proviral
NA) but not the cotransfected plasmid DNA or the
inear preintegration intermediates (Fig. 6A). The results
howed that a distinct band of 984 bp representing the
roduct of unmodified one-LTR proviral DNA circles was
etected for both pTVDCMVnlacZ and pTVDCT-CMVn-
acZ (Fig. 6B, lanes 3 and 5). In contrast, the size of the
3-deleted proviral DNAs of pTVDCMVnlacZdl39U3#1 (39
3 deleted) and pTVDCT-CMVnlacZdl39U3#1 (both 59
nd 39 U3 deleted) was shifted down to 552 bp (Fig. 6B,
anes 4 and 6), which was consistent with the expected
eletion size of U3. Southern analysis of the PCR-ampli-
ied products did not detect wild-type U3 signal in pro-
irus of the U3-deleted vector constructs (not shown).
his result demonstrates that both the single and the
ouble U3-deleted constructs can be properly reverse
FIG. 5. Mutagenesis and PCR primers and their relative locations on
t the top. The location and direction of these primers are also depictranscribed after transduction. Tubstitution of 39 U5 with a heterologous
olyadenylation signal increased vector titer
To delete more LTR sequences from pTV, the 39 U5
as further modified. We first deleted the entire 39 U5
nd generated pTVDCMVnlacZdl39U3#1U5 using mu-
agenesis primer g listed in Fig. 5 (Fig. 7A). This deletion
ed to a severe loss of vector function as determined by
ector titration assay (12% of wild-type level, Fig. 7A).
orthern analysis showed marked reduction of genome-
ized mRNA to an undetectable level (not shown). These
esults suggested a possible defect in polyadenylation
nd/or stability of mRNA. Accordingly, we substituted U5
ith a heterologous polyadenylation sequence derived
rom bovine growth hormone (bGH) gene and generated
new pTV construct, pTVDCMVnlacZdl39U3#1U5pA.
nalyses of this construct showed an improved vector
unction almost twice as high as that of the wild type.
rious primers for PCR mutagenesis are set on the pTV map as shownpTV. Vahis was confirmed when the 39 U5 of the previously
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126 IWAKUMA, CUI, AND CHANGodified pTVDCT-dl39U3#1, which had 59 and 39 U3
odifications, was also replaced with the bGHpA and
ested (pTVDCT-CMVnlacZdl39U3#1U5pA, Fig. 7A).
To see if these modified vectors can efficiently infect
ondividing cells, we blocked the cell cycle of TE671
ells by g-irradiation (20,000 rad) and then transduced
hese irradiated cells with different LTR-modified vectors
Fig. 7B). The transduction efficiencies of these vectors
ere studied in both dividing and nondividing cells and
ompared with that of the wild-type pTV. The titer of
ild-type pTV on irradiated cells was determined to be
.94 6 0.05 in relation to wild-type pTV on dividing cells
hich was arbitrarily set at 1 (Fig. 7B, a). In addition, the
iters of both the 39 U3/U5- and 59U3–39U3/U5-modified
ectors on irradiated cells were comparable to that on
onirradiated cells (Fig. 7B, b and c vs d). These results
onfirmed that LTR-modified lentiviral vectors trans-
uced both dividing and nondividing cells at similar ef-
iciencies.
To examine the SIN phenotype of the pTV vectors with
9 U3/U5 deletion, a provirus recovery experiment, as
llustrated in Fig. 2, was performed. TE671 cells were
FIG. 6. Detection of proviral DNA after lentiviral vector transduction. H
ransduction and amplified by PCR using two nested primer pairs. (A)
eleted in 39 U3. (B) Detection of proviral DNA. The expected fragment s
n the right. A 250-bp DNA ladder was used as a size marker; lane 1,
ane 4, pTVDCMVnlacZdl39U3#1; lane 5, pTVDCT-CMVnlacZ; and laneransduced with wild-type pTV and the modified tl39U3#1U5pA vectors and continuously cultured for 33
ays until passage 10. The long-term propagation of the
ransduced cells would reduce the level of contaminating
arryover transfection DNA and the extrachromosomal
roviral DNA. The percentages of transduced cells in
hese passage 10 cultures were determined by X-gal
taining to be 50 and 55% for pTVDCMVnlacZ and
TVDCMVnlacZdl39U3#1U5pA, respectively (not shown).
o recover packageable proviral RNA, these cultures
ere transfected with the lentiviral helper construct
HPdl20, the pseudotype env construct pHEF-VSVG, and
CEP4tat to enhance LTR transactivation, and 48 h later
he culture supernatants were harvested and assayed on
E671 cells. The average of four repeated assays is
hown in Table 1. The cells transduced by
TVDCMVnlacZ released more than 104 per milliliter of
nfectious vectors, whereas cells transduced by
TVDCMVnlacZdl39U3#1U5pA released zero infectious
nits of viral vector. This result suggests that there is no
TR-derived full-length RNA present in cells transduced
ith pTVDCMVnlacZdl39U3#1U5pA and that the provirus
erived from the SIN vector does not have a transcrip-
was harvested as described under Materials and methods 12 h after
gration intermediate diagram. Hatched box shows the 432-bp region
one-LTR circles of wild-type and U3-deleted pTV constructs are shown
without template; lane 2, mock transduction; lane 3, pTVDCMVnlacZ;
DCT-CMVnlacZdl39U3#1.irt DNA
RT inte
izes for
primersionally active LTR after integration.
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127IMPROVED LENTIVIRAL SIN VECTORS9 U5 is critical to optimal vector function
To further improve this vector system, we attempted to
elete the 59 U5 sequence by PCR mutagenesis using
rimers j–l as listed in Fig. 5. A pTV mutant with the entire
9 U5 deleted except for the 24-nt attR was first made and
FIG. 7. Generation of 39 U5-deleted SIN vectors and transduction of
eleted by PCR mutagenesis as described under Materials and Me
olyadenylation sequence was inserted at the HindIII site in the 39 R. T
elative titers to the control pTVDCMVnlacZ were determined and sh
ild-type pTV construct was 7.3 6 0.2 3 105. (B) Lentiviral transduction
a), pTVDCMVnlacZdl39U3#1U5pA (b), and pTVDCT-CMVnlacZdl39U3#
E671 cells (d), and 48 h later, the transduced cells were fixed and
icroscope (10 3 10). The enlarged morphological change of irradiated
fficiency is presented under each photo as relative vector titers (n 5xamined. The titration assay showed that this U5 deletion ronstruct, pTVDCMVnlacZdl59U5D62-39U3U5pA, exhibited
nly 30% of the wild-type vector function (D62, Fig. 8). When
he 59 12 and 27 nt of U5 were added back to the D62
onstruct to generate the D50 and D35 pTV mutants, re-
pectively, the titration assay showed that the D50 construct
iding cells. (A) pTV vectors with 39 U5 modifications. The 39 U5 was
(pTVDCMVnlacZdl39U3#1U5). In pTVDCMVnlacZdl39U3#1U5pA, bGH
e modifications were introduced into the 59 U3-replaced pTV vectors.
the right with standard errors (n 5 4). The actual titer value of the
ding and nondividing cells. Viral vectors derived from pTVDCMVnlacZ
(c and d) were used to transduce both irradiated (a to c) and normal
d with X-gal and photographed under a Zeiss Axiovert 25 inverted
a to c) was apparently different from normal cells (d). The transduction
actual titer value of the wild-type pTV construct was 6.9 6 0.1 3 105.nondiv
thods
he sam
own on
of divi
1U5pA
staine
cells (
4). Theestored 20% of vector function. Interestingly, the D35 con-
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128 IWAKUMA, CUI, AND CHANGtruct restored vector efficiency close to the level of wild-
ype pTVDCMVnlacZ. Nevertheless, compared with its pa-
ental construct pTVDCMVnlacZdl39U3#1U5pA, the D35
ector function was still reduced by 50%.
FIG. 7
TABLE 1
Recovery of Lentiviral Vectors from Transduced TE671 Cells
Proviral cultures
Titer of recovered vectors
(6standard error)
TVDCMVnlacZ 1.12 3 104 6 0.13
TVDCMVnlacZdl39U3#1U5pA 0
Note. Provirus-integrated cultures 33 days after transduction were
ransfected with pHPdl20, pHEF-VSVG, and pCEP4tat, and 48 h later
upernatants were used to infect TE671 cells as described in the text.hhe titer represents averages of three experiments.DISCUSSION
In this study, we sequentially deleted U3 and U5 se-
uences of both LTRs of a lentiviral transducing vector
onstruct, pTV, to generate an improved SIN vector. pHP
rovides helper viral gene functions and pTV produces
ackageable genome. pHP does not have any LTR se-
uence because the 59 LTR had been replaced with a
himeric CMV-IE enhancer/promoter and the 39 LTR had
een replaced with an SV40 polyadenylation signal. The
TRs in pTV, however, have potential risk of generating
eplication-competent HIV upon recombination with pHP.
hus, deleting LTRs in pTV would eliminate all native HIV
TR sequences in the vector system and greatly improve
he safety of the HP/TV vector system. The replacement
f both pHP and pTV LTRs with the same CMV-IE en-
uedancer/promoter, however, may not be desirable be-
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129IMPROVED LENTIVIRAL SIN VECTORSause it increases the possibility of generating a recom-
inant virus carrying a heterologous CMV-IE promoter.
evertheless, this can be avoided by replacing the pHP
r the pTV promoter with a heterologous promoter. The
eplacement of 59 U3 with a truncated CMV-IE enhancer/
ATA promoter did not affect vector efficiency and this
himeric promoter appears to act like the native HIV-1
romoter in TE671 cells (Fig. 3B). Others have reported
imilar replacement with a full-length CMV-IE enhancer
nd illustrated a tat-independent promoter function using
different lentiviral vector system (Kim et al., 1998; Miyo-
hi et al., 1998). Although the truncated CMV-IE enhanc-
r/TATA promoter in pTVDCT-CMVnlacZ appears to have
lightly higher basal promoter activity than that of the
ative HIV LTR in the absence of Tat as demonstrated in
epeated Northern analyses (Fig. 3B), Tat is still required
or high vector efficiency in our system.
It appears that except for the first 24 nt of 39 U3 which
ontains the left integrase attachment site (attL), all U3
equences could be deleted without affecting vector
unction. This result is in agreement with the studies of
FIG. 8. Analyses of 59 U5 pTV deletion mutants. 59 U5 was deleted by
f deletions are indicated (D62, D50, and D35). Relative titers to pTVD
f the wild-type pTV construct was 7.3 6 0.2 3 105.iyoshi et al. (1998) and Zufferey et al. (1998). However, te found that the deletion of USE in the 39 U3 had a mild
ffect on vector titer (;20% reduction). This could be due
o the ineffectiveness of poly(A) processing, because the
nteraction of a 160-kDa subunit of cleavage and polyad-
nylation specificity factor (CPSF) with USE is known to
nhance poly(A) processing (Gilmartin et al., 1992, 1995;
alsamakis et al., 1991). The GU-rich or U-rich element in
5 is known to be associated with the cleavage stimu-
ation factor (CstF), which is important for modulating
NA polyadenylation (Keller, 1995; MacDonald et al.,
994). This could explain why deletion of 39 U5 led to a
evere reduction in vector titer and mRNA synthesis.
his defect could be overcome by replacing sequence
ownstream of the polyadenylation signal, AATAAA, with
GH poly(A) sequence (Fig. 7A). The resulting vector
roduced two times the titer of the parental
TVDCMVnlacZ, which is more than 1 3 106/ml.
Further deletion of 59 U5 of pTV is less tolerable (Fig.
). Since 59 U5 has been shown to have multiple roles
ncluding packaging, reverse transcription, and integra-
ion, the defect of the 59 U5-deleted vector may be mul-
utagenesis as described under Materials and Methods and the sizes
cZ are presented with standard errors (n 5 4). The actual titer valuePCR m
CMVnlaifactorial (Das et al., 1997; Huang et al., 1998; Vicenzi et
a
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130 IWAKUMA, CUI, AND CHANGl., 1994). Vicenzi et al. (1994) have reported that the
iddle part of 59 U5 could be deleted without affecting
IV-1 replication, while deletions of either 59 or 39 one-
hird impaired virus replication. Results of the three pTV
9 U5 deletion constructs are consistent with those ear-
ier observations. Further analyses will be necessary to
ee how 59 U5 interferes with vector function.
In summary, we have generated a modified lentiviral
ector system with most of the native HIV LTR sequences
eleted without affecting its function of transducing non-
ividing cells. The LTR-deleted vector exhibited vector
fficiency similar to or better than that of the parental
ector. Future steps will be taken to replace the remain-
ng 59 U5 sequence and the native HIV R sequence so
hat the pTV vector will contain only minimal native HIV
enome sequence.
MATERIALS AND METHODS
ell culture
TE671 (human rhabdomyosarcoma) cells were ob-
ained from ECACC, England. Cells were maintained in
ulbecco’s modified Eagle’s medium (DMEM, Media-
ech) supplemented with 10% fetal bovine serum (FBS,
ibco BRL) and 100 units/ml of penicillin–streptomycin
Gibco BRL).
lasmid constructions
pTVDCMVnlacZ, pHPdl20, pHEF-VSVG, and pCEP4tat
ere constructed as described previously (Chang et al.,
999) and are illustrated in Figs. 1A and 1B. Replacement
f 59 U3 with a truncated CMV-IE enhancer/TATA pro-
oter was accomplished by replacing StuI to NsiI of
TVDCMVnlacZ with PmeI to NsiI of CMV-IE (a)/TATA-
IV-1NL4–3 (Chang et al., 1993). To generate
TVDCMVnlacZdl39U3kB/Sp1, a DNA fragment from
l.kB/Sp1-HIV-1NL4–3 (Adachi et al., 1986; Chang et al.,
993; Hunninghake et al., 1989) digested with KpnI and
goMI was cloned into pTVDCMVnlacZ. To construct
TV mutants by PCR mutagenesis, the primers listed in
ig. 5 were used. For 39 U3 deletions, primers a and c–f
ere used in the first round of PCR, using
TVDCMVnlacZ as a template. The amplified products
ere purified by Microcon 50 (AMICON) and used as a
ega-primer to pair with 39 primer b for the second-
ound PCR using pTVDCMVnlacZ as template. The am-
lified fragments were digested with EcoRI and NgoMI
nd cloned into pTVDCMVnlacZ. To generate
TVDCMVnlacZdl39U3#1U5, pTVDCMVnlacZdl39U3#1
as used as template and primer g was used as 39
rimer in the first-round PCR. The rest of the cloning
teps were similar to that of the 39 U3 deletion construc-
ion. To generate 59 U5 deletions, primers h and j–l were
sed for the first-round PCR with pTVDCMVnlacZ asemplate. The products were used as mega-primers to tair with 39 primer i in the second-round PCR. The final
CR products were digested with BspEI and NsiI and
loned into pTVDCMVnlacZdl39U3#1U5pA. All PCR-am-
lified sequences were verified by DNA sequencing.
pTVDCMVnlacZdl39U3#1U5pA was constructed by di-
esting pcDNA3.1/Zeo(1) (Invitrogen) with HindIII and
goMI and a 512-bp DNA fragment containing bGH poly-
denylation sequence was isolated and cloned into
TVDCMVnlacZdl39U3#1 digested with the same en-
ymes.
NA transfection
A modified calcium phosphate DNA transfection pro-
ocol was performed as previously described (Chang
nd Zhang, 1995; Chen and Okayama, 1987). Transfec-
ion efficiency was determined by a radioimmunoassay
or human growth hormone that was produced by a
otransfected plasmid pXGH5 (Nichols Institute Diag-
ostics). Supernatants of transfected culture were col-
ected and used for both human growth hormone and
irus titration assays.
ector production and titration
To produce lentiviral vectors, 10 mg of pTV, 10 mg of
HPdl20, and 5 mg of pHEF-VSVG were cotransfected
ith 1 mg of a tat-encoding plasmid pCEP4tat and 0.1 mg
f pXGH5 into TE671 cells (5 3 105) in each well of a
-well plate the day before transfection. Media were
hanged 18–24 h after DNA was added, and the follow-
ng day virus was harvested by filtration using 0.45-mm
ow-protein binding filters (Millex-HV, Millipore) to re-
ove cell debris. The supernatants were stored at
80°C in aliquots until use. For vector titration, two
ifferent dilutions of supernatants were used to infect
3 104 TE671 cells plated in 24-well plates in the
resence of 8 mg/ml of polybrene. After 3–4 h of infection,
resh media were added, and 48 h after infection, culture
as stained with X-gal substrate as previously described
Chang et al., 1999). Virus titer was determined by count-
ng the blue nucleated cells and relative vector titer to the
ild-type control was presented after normalization for
ransfection based on control human growth hormone
xpression.
entiviral transduction of irradiated TE671 cells
TE671 cells were irradiated with 20,000 rad and main-
ained in a 5% CO2 incubator for 28 h before transduction.
he irradiated cells were transduced with lentiviral vec-
ors at different multiplicity of infection and 48 h later,
ells were assayed for lacZ reporter gene expression by
-gal staining, and the transduction efficiency was de-ermined.
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131IMPROVED LENTIVIRAL SIN VECTORSirt DNA preparation
A modified protocol was used for simultaneous prep-
ration of genomic and Hirt DNA (Motmans et al., 1997).
riefly, cells were resuspended in 250 ml buffer contain-
ng 50 mM glucose, 25 mM Tris–HCl (pH 8.0), and 10 mM
DTA after washing with PBS and incubated at room
emperature for 5 min. Cells were then lysed with 200 ml
ysis buffer containing 200 mM NaOH and 1% SDS on ice
or 5 min. The lysate was neutralized by adding 150 ml of
M potassium acetate (pH 4.8), and cell debris and
hromosomal DNA were pelleted by centrifugation at
0,000 g for 5 min. The supernatant containing Hirt DNA
as treated with proteinase K, extracted with phenol and
hloroform, and followed by ethanol precipitation.
CR analysis of unintegrated proviral intermediates
Approximately 100 ng of Hirt DNA was used as tem-
late to detect proviral intermediates using a nested PCR
ethod. Hirt DNA was purified from cells infected with
entiviral vectors for 12 h. For the first round of PCR, a 59
rimer in lacZ, 59-ACG ACT CCT GGA GCC CG-39, and a
9 primer in gag, 59-TGT GTT GAA TTA CAG TAG AAA
AT TCC CCT C-39, were used. For the second-round
CR, another 59 primer in lacZ downstream of the first
acZ primer, 59-GGC GGA ATT CCA GCT GAG-39, and
nother 39 primer in gag upstream of the first 39 primer,
9-ACT GAC GCT CTC GCA CCC AT-39, were used. An-
ealing temperature was 58°C and PCR was performed
or 30 cycles for both rounds.
ytoplasmic poly(A)1 RNA purification and
orthern blotting
TE671 cells were seeded into a six-well plate at 5 3
05 cells per well 1 day before transfection. To drive the
xpression of packageable full-length mRNA from a pTV
lasmid, a Rev-expression plasmid, pCMVrev, which is
mportant for the nuclear export of genomic RNA, was
otransfected with the pTV plasmid. Cells were trans-
ected with 20 mg of pTV or its derivatives, 1 mg of pXGH5
or transfection control, and 4 mg of pCMVrev with or
ithout 2 mg of pCEP4tat per well. Media were changed
he next day and the following day, cytoplasmic poly(A)1
NA was harvested for Northern analyses as previously
escribed (Chang and Zhang, 1995; Robinson et al.,
995). The RNA blot was hybridized with a lacZ probe
nd rehybridized with a chicken b-actin probe to normal-
ze RNA amounts. Before rehybridization, the first probe
as stripped off by boiling the blot in ddH2O containing
.1% SDS for 5 min.
ecovery of integrated lentiviral vectors
The cells infected by virus derived from
TVDCMVnlacZ and pTVDCT-CMVnlacZdl39U3#1U5pA
ere cultured for 33 days (passage 10). These cells wereransfected with 15 mg of pHPdl20, 10 mg of pHEF-VSVG,
mg of pCEP4tat, and 0.1 mg of pXGH5 plasmids as
escribed above. After 48 h, 20, 10, and 200 ml of the
ransfection supernatants, containing 8 mg/ml of poly-
rene, were used to infect TE671 cells for vector titration
s described above.
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